Anavex Life Sciences Corp (AVXL)

[investingdog]

Oh, absolutely, because nothing screams 'successful drug launch' like relying on the endless patience of shorts to keep the stock pitifully controlled for a 'while.' And of course, Blarcamesine will definitely just casually ramp up sales after all the FDA nods, like it’s just another over-the-counter eye drop for millions waiting to happen. Meanwhile, the stock’s just casually hanging out in single digits, no pressure, just a modest 'Strong Buy' rating and a price target tripling from here. Slow and steady, right? Totally not the plan to explode overnight or anything.